- Home
- ABEO vs BLND Comparison
ABEO vs BLND Comparison
Compare ABEO & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | BLND |
|---|---|---|
| Founded | 1974 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 355.9M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABEO | BLND |
|---|---|---|
| Price | $5.45 | $1.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $20.00 | $4.13 |
| AVG Volume (30 Days) | 1.0M | ★ 4.4M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 58.33 |
| EPS | N/A | ★ N/A |
| Revenue | $2,998,000.00 | ★ $123,585,000.00 |
| Revenue This Year | $1,024.31 | $12.62 |
| Revenue Next Year | $145.42 | $14.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $1.18 |
| 52 Week High | $7.54 | $4.49 |
Technical Indicators
Market Signals| Indicator | ABEO | BLND |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 51.92 |
| Support Level | $5.20 | $1.56 |
| Resistance Level | $5.54 | $1.67 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 39.88 | 48.84 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.